olpadronic acid has been researched along with Bone Loss, Osteoclastic in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 9 (47.37) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachmann, R; Bisping, M; Born, AR; Cortesi, R; Glatt, M; Green, JR; Guiglia, G; Jaeggi, KA; Jeker, H; Klein, R; Müller, K; Ramseier, U; Schmid, J; Schreiber, G; Seltenmeyer, Y; Widler, L | 1 |
| Engelbert, R; Jansen, M; Kok, D; Pruijs, H; Sakkers, R; Schweitzer, D; Uiterwaal, C; van Dongen, A; Verbout, A | 1 |
| De Grandi, MC; Friedman, S; Gamba, CA; Mandalunis, P; Somoza, J; Tomat, A; Zeni, S | 1 |
| Goya, JA; Mandalunis, PM; Paez, HA | 1 |
| Kurth, KH; Löwik, C; Papapoulos, S; Schamhart, D; Theuns, H; Weissglas, M | 1 |
| Bloys, H; Löwik, C; Oostendorp-van de Ruit, M; Papapoulos, S; van Beek, E; van de Bent, C; van der Wee-Pals, L | 1 |
| Bijvoet, OL; Papapoulos, SE; Schweitzer, DH; Vermeij, P; Zwinderman, AH | 1 |
| Löwik, C; Papapoulos, S; Que, I; Van Beek, E | 1 |
| Gomez-Acotto, C; Mautalen, C; Zeni, S | 1 |
| Brown, RJ; Löwik, CW; Papapoulos, SE; van Beek, E; Watts, DJ | 1 |
| Hamdy, NA; Lycklama à Nijeholt, AA; Papapoulos, SE; Pelger, RC; Zwinderman, AH | 1 |
| Cohen, L; Löwik, C; Papapoulos, S; Pieterman, E; van Beek, E | 1 |
| Berenson, J; Hortobagyi, G; Lipton, A; Major, PP | 1 |
| Löwik, CW; Papapoulos, SE; Van Beek, ER | 1 |
| Gomez, AC; Gregorio, S; Mautalen, C; Somoza, J; Zeni, SN | 1 |
| Alblas, MJ; Bijvoet, OL; de Groot, H; Löwik, CW; Papapoulos, SE; van der Pluijm, G; van der Wee-Pals, LJ | 1 |
| Hoekman, K; Papapoulos, SE; Tjandra, YI | 1 |
| Bijvoet, OL; Hoekman, K; Löwik, CW; Papapoulos, SE; Vermeij, P | 1 |
| Bijvoet, OL; Löwik, CW; van der Pluijm, G; van der Wee-Pals, LJ; van Treslong-De Groot, HB | 1 |
1 review(s) available for olpadronic acid and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Oral bisphosphonates: A review of clinical use in patients with bone metastases.
Topics: Alendronate; Biological Availability; Bone Density; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcium; Clodronic Acid; Diphosphonates; Double-Blind Method; Etidronic Acid; Humans; Ibandronic Acid; Imidazoles; Male; Multiple Myeloma; Pamidronate; Prostatic Neoplasms; Pyridines; Randomized Controlled Trials as Topic; Risedronic Acid; Zoledronic Acid | 2000 |
2 trial(s) available for olpadronic acid and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study.
Topics: Activities of Daily Living; Administration, Oral; Adolescent; Bone Density; Bone Resorption; Child; Child, Preschool; Diphosphonates; Double-Blind Method; Female; Fractures, Spontaneous; Humans; Locomotion; Male; Osteogenesis Imperfecta | 2004 |
Effects of the bisphosphonate olpadronate in patients with carcinoma of the prostate metastatic to the skeleton.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alkaline Phosphatase; Antineoplastic Agents; Bone Neoplasms; Bone Resorption; Calcium; Diphosphonates; Follow-Up Studies; Humans; Hydroxyproline; Injections, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Osteoblasts; Pain; Prostatic Neoplasms | 1998 |
16 other study(ies) available for olpadronic acid and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa).
Topics: Animals; Bone Resorption; Calcitriol; Diphosphonates; Hypercalcemia; Imidazoles; In Vitro Techniques; Kidney; Mice; Pamidronate; Parathyroidectomy; Rats; Skull; Structure-Activity Relationship; Thyroidectomy; Zoledronic Acid | 2002 |
Changes in bone volume and bone resorption by olpadronate treatment in an experimental model of uremic bone disease.
Topics: Alkaline Phosphatase; Amino Acids; Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Calcium; Creatinine; Diphosphonates; Disease Models, Animal; Kidney; Male; Phosphorus; Rats; Uremia | 2005 |
Effect of topical administration of monosodium olpadronate on experimental periodontitis in rats.
Topics: Administration, Topical; Alveolar Bone Loss; Alveolar Process; Animals; Bone Density Conservation Agents; Bone Resorption; Cell Nucleus; Cell Polarity; Cell Shape; Diphosphonates; Furcation Defects; Male; Mandible; Osteoblasts; Osteoclasts; Periodontal Ligament; Periodontitis; Rats; Rats, Wistar | 2006 |
Bone resorption and renal calcium reabsorption in renal cell carcinoma-bearing mice: the effects of bisphosphonate.
Topics: Animals; Bone Density Conservation Agents; Bone Resorption; Calcium; Carcinoma, Renal Cell; Diphosphonates; Humans; Hypercalcemia; Kidney Neoplasms; Mice; Mice, Nude | 2007 |
Effects of experimental conditions on the release of 45calcium from prelabeled fetal mouse long bones.
Topics: Acid Phosphatase; Animals; Bone Marrow Cells; Bone Resorption; Calcium; Calcium Radioisotopes; Cells, Cultured; Culture Techniques; Diphosphonates; Dose-Response Relationship, Drug; Growth Inhibitors; Interleukin-6; Isoenzymes; Leukemia Inhibitory Factor; Lymphokines; Metacarpus; Metatarsal Bones; Mice; Osteoclasts; Parathyroid Hormone; Radius; Stromal Cells; Tartrate-Resistant Acid Phosphatase; Ulna | 1995 |
Improved treatment of Paget's disease with dimethylaminohydroxypropylidene bisphosphonate.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bone Resorption; Diphosphonates; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Middle Aged; Osteitis Deformans; Pamidronate; Remission Induction | 1993 |
Dissociation of binding and antiresorptive properties of hydroxybisphosphonates by substitution of the hydroxyl with an amino group.
Topics: Amines; Analysis of Variance; Animals; Binding Sites; Bone Matrix; Bone Resorption; Calcium Oxalate; Crystallization; Diphosphonates; Etidronic Acid; Female; Mice; Pamidronate; Pregnancy; Structure-Activity Relationship | 1996 |
The effect of olpadronate in ovariectomized thyroxine-treated rats.
Topics: Alkaline Phosphatase; Animals; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Creatinine; Diphosphonates; Estrogens; Female; Humans; Hydroxyproline; Hyperthyroidism; Osteoporosis, Postmenopausal; Ovariectomy; Rats; Rats, Sprague-Dawley; Thyroxine | 1997 |
Differential effects of aminosubstituted analogs of hydroxy bisphosphonates on the growth of Dictyostelium discoideum.
Topics: Amines; Animals; Bone Density; Bone Resorption; Dictyostelium; Diphosphonates; Dose-Response Relationship, Drug; Etidronic Acid; Female; Hindlimb; Mice; Pamidronate; Structure-Activity Relationship | 1998 |
Nitrogen-containing bisphosphonates inhibit isopentenyl pyrophosphate isomerase/farnesyl pyrophosphate synthase activity with relative potencies corresponding to their antiresorptive potencies in vitro and in vivo.
Topics: Animals; Bone Resorption; Brain; Carbon-Carbon Double Bond Isomerases; Cattle; Clodronic Acid; Dimethylallyltranstransferase; Diphosphonates; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Hemiterpenes; Ibandronic Acid; Mice; Multienzyme Complexes; Nitrogen; Pamidronate | 1999 |
Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on
Topics: Animals; Bone Resorption; Calcium; Diphosphonates; In Vitro Techniques; Mice; Osteoblasts; Osteoclasts; Osteogenesis; Protein Prenylation; Stem Cells; Temperature | 2002 |
Olpadronate prevents the bone loss induced by cyclosporine in the rat.
Topics: Absorptiometry, Photon; Administration, Oral; Alkaline Phosphatase; Amino Acids; Animals; Bone and Bones; Bone Density; Bone Resorption; Cyclosporine; Diphosphonates; Disease Models, Animal; Dose-Response Relationship, Drug; Immunosuppressive Agents; In Vitro Techniques; Injections, Intraperitoneal; Male; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2002 |
Modulation of PTH-stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants.
Topics: Animals; Bone Resorption; Calcium; Clodronic Acid; Culture Techniques; Diphosphonates; Dose-Response Relationship, Drug; Drug Synergism; Female; Mice; Mice, Inbred Strains; Pamidronate; Parathyroid Hormone; Pregnancy | 1991 |
The role of 1,25-dihydroxyvitamin D in the maintenance of hypercalcemia in a patient with an ovarian carcinoma producing parathyroid hormone-related protein.
Topics: Aged; Bone Resorption; Calcitriol; Calcium; Diphosphonates; Female; Humans; Hypercalcemia; Ovarian Neoplasms; Pamidronate; Paraneoplastic Endocrine Syndromes; Parathyroid Hormone-Related Protein; Proteins | 1991 |
Application of an in vitro model and a clinical protocol in the assessment of the potency of a new bisphosphonate.
Topics: Administration, Oral; Aged; Animals; Bone and Bones; Bone Resorption; Clinical Protocols; Diphosphonates; Humans; Hydroxyproline; Infusions, Intravenous; Mice; Middle Aged; Models, Biological; Organ Culture Techniques; Osteitis Deformans; Pamidronate; Prospective Studies | 1989 |
Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: the effect of a bisphosphonate.
Topics: Animals; Bone Marrow Cells; Bone Matrix; Bone Resorption; Cell Adhesion; Cell Communication; Cell Movement; Diphosphonates; Female; Fetus; Liver; Mice; Organ Culture Techniques; Osteoclasts | 1988 |